MERIT’s EXCELSIORTM technology platform increases accuracy and efficiency by providing a suite of advanced endpoint analysis tools designed based on our extensive collaboration with biopharma companies.
With MERIT your study data and images can easily be shared between clinical sites, reading centers, CROs, and Sponsors for maximum transparency. This makes managing global trials involving multiple reading centers and analysis of numerous modalities not only feasible, but practical.
Erickson, B. J., Kirk, S., Lee, Y., Bathe, O., Kearns, M., Gerdes, C., Rieger-Christ, K., & Lemmerman, J. (2016). The Cancer Genome Atlas Liver Hepatocellular Carcinoma Collection (TCGA-LIHC) (Version 5) [Data set]. The Cancer Imaging Archive. https://doi.org/10.7937/K9/TCIA.2016.IMMQW8UQ